Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia.

Slappendel, R.; Huvers, F.C.; Benraad, B.; Nováková, I.R.O.; Hellemondt, G. van

research article

oai:repository.ubn.ru.nl:2066/185524

Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia.

Authors: R. Slappendel
F.C. Huvers
B. Benraad
I.R.O. Nováková
G. van Hellemondt
Publication date: 1 January 2002
Publisher: 'Ovid Technologies (Wolters Kluwer Health)'
Doi

Abstract

Item does not contain fulltex

Similar works

Full text

Radboud Repository (Radboud Univ.)

oai:repository.ubn.ru.nl:2066/...

Last time updated on 11/04/2018

This paper was published in Radboud Repository (Radboud Univ.).

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.